Sunday, January 24, 2010

Creatine Helps Prevent Muscle Loss Even When in a Cast. Read more...
http://bit.ly/6dduNx

Creatine Controls Blood Glucose as Well as Metformin (Glucophage)
Read more...
http://bit.ly/6HBXkk

80% of Gastric Bypass patients Vitamin D Defficient
Read more...
http://bit.ly/UdHt7

Why is the Short MGB Good? Longer Operative is independently associated with increased Infectious Complications
http://bit.ly/8IGYAi

Iron Deficiency Anemia and Gastric Bypass
http://bit.ly/6K5A34
Introduction

“Bariatric surgery is an effective treatment for patients with clinically severe obesity. In addition to significant weight loss, it is also associated with improvements in comorbidities. Unfortunately, bariatric surgery also has the potential to cause a variety of nutritional and metabolic complications. These complications are mostly due to the extensive surgically induced anatomical changes incurred by the patient's gastrointestinal tract, particularly with roux-en-Y gastric bypass and biliopancreatic diversion. ...

Saturday, January 16, 2010

http://ping.fm/qke7w
Impact of Dexmedetomidine on Analgesic Requirements in Patients after Cardiac Surgery in a Fast-track Recovery Room Setting

http://ping.fm/c4iqe
Effects of television viewing reduction on energy intake

http://ping.fm/0q4Fd
H. pylori and Peptic Ulcer

On this page:

* What is a peptic ulcer?
* What is H. pylori?
* How does H. pylori cause a peptic ulcer?
* What are the symptoms of an ulcer?
* How is an H. pylori-related ulcer diagnosed?
* How are H. pylori peptic ulcers treated?
* Drugs Used to Treat H. pylori Peptic Ulcers
* Can H. pylori infection be prevented?
* Why don’t all doctors automatically check for H. pylori?
* Points to Remember

Monday, November 09, 2009

http://ping.fm/mc9wN

Mini Gastric Bypass Surgeon Costa Rica Carlos Quesada

Mini Gastric Bypass Surgeon from Costa Rica, Dr. Carlos Quesada talks about MGB:

Another trial of the treatment of diabetes the Mini-Gastric Bypass was
roughly TWICE as effective as the Sleeve Gastrectomy

http://ping.fm/Zz1mW

Friday, October 30, 2009

My eye doctor, Evan Wolf, MD, PhD was telling me that I had bad eys with lots of complications. I told him my sugar was better, at 5.7 and I said I was hoping that my eyes had improved and he said "We'll see". So he sits down and shines that bright light in my eye so he can look deep inside and he says, "I can't believe this, all the damage you had, is completely gone! It's like you have new eyes. I've NEVER seen that happen before. He was so excited!!

I did have to get a new prescription though, cause now I need a magnifier for up close, no glasses for the tv or computer and then something for far away if I"m driving.

And he took me off the Acetazolamide. The only med I have to take is the Synthroid.

Good news
Cindy T
Alaska

Sunday, October 25, 2009

http://ping.fm/hOojs
Lap Band Less Effective than Stomach Stapling 3
Laparoscopic Adjustable Silicone Gastric Banding vs Laparoscopic Vertical Banded Gastroplasty in Morbidly Obese Patients: Long-Term Results of a Prospective Randomized Controlled Clinical Trial

Level I Evidence: The Lap Band is inferior to the old stomach stapling

Saturday, October 24, 2009

http://ping.fm/qlJV6

Lap Band worse than stomach stapling.
Controlled prospective trial shows the old stomach stapling is better than the band!
;-(

Wednesday, October 21, 2009

Dr. Rutledge,
Like some of the people I have seen on your videos on you tube, I found your name after typing in failed lap-band. I have had my band for 3 years after I let myself be talked into it by my best friend. The vomiting is awful and has almost put a complete stop to my life for weeks on end as I try to get things under control time and time again. My question is do you ever just remove a lap band without doing the MGB surgery? I feel as though I am done with this and am slowly losing my mind as well as my health.
Thank you and thank you for this site which makes me feel not so alone.
J

The Comparative Dose-Response Effects of Melatonin and Midazolam for Premedication of Adult Patients: A Double-Blinded, Placebo-Controlled Study
Mohamed Naguib, MB, BCh, MSc, FFARCSI, MD*, and Abdulhamid H. Samarkandi, MB, BS, KSUF, FFARCSI{dagger}

Departments of Anesthesia, *University of Iowa College of Medicine, Iowa City, Iowa, and {dagger}King Saud University, Riyadh, Saudi Arabia

Address correspondence and reprint requests to Mohamed Naguib, MD, University of Iowa College of Medicine, Department of Anesthesia, 200 Hawkins Dr., 6JCP, Iowa City, Iowa 52242-1009. Address e-mail to mohamed-naguib@uiowa.edu.

We designed this prospective, randomized, double-blinded, placebo-controlled study to compare the perioperative effects of different doses of melatonin and midazolam.

Doses of 0.05, 0.1, or 0.2 mg/kg sublingual midazolam or melatonin or placebo were given to 84 women, approximately 100 min before a standard anesthetic.

Sedation, anxiety, and orientation were quantified before, 10, 30, 60, and 90 min after premedication, and 15, 30, 60, and 90 min after admission to the recovery room.

Psychomotor performance of the patient was evaluated at these times also, by using the digit-symbol substitution test and Trieger dot test.

Patients who received premedication with either midazolam or melatonin had a significant decrease in anxiety levels and increase in levels of sedation preoperatively compared with control subjects.

Patients in the three midazolam groups experienced significant psychomotor impairment in the preoperative period compared with melatonin or placebo.

After operation, patients who received 0.2 mg/kg midazolam premedication had increased levels of sedation at 90 min compared with 0.05 and 0.1 mg/kg melatonin groups. In addition, patients in the three midazolam groups had impairment of performance on the digit-symbol substitution test at all times compared with the 0.05 mg/kg melatonin group.

Premedication with 0.05 mg/kg melatonin was associated with preoperative anxiolysis and sedation without impairment of cognitive and psychomotor skills or affecting the quality of recovery.

Implications:

Premedication with 0.05 mg/kg melatonin was associated with preoperative anxiolysis and sedation without impairment of cognitive and psychomotor skills or affecting the quality of recovery.

http://sites.google.com/a/clos.net/mini/melatonin
Melatonin

Anesth Analg 2007; 105:1263-1271
© 2007 International Anesthesia Research Society
ANESTHETIC PHARMACOLOGY
The Clinical Impact of Preoperative Melatonin on Postoperative Outcomes in Patients Undergoing Abdominal Hysterectomy

Wolnei Caumo, MD, PhD*{dagger}, Fernanda Torres, MSc{ddagger}, Nívio L. Moreira, Jr, MD§, Jorge A. S. Auzani, MD§, Cristiano A. Monteiro, MD§, Gustavo Londero, MD§, Diego F. M. Ribeiro||, and Maria Paz L. Hidalgo, MD, PhD||

From the *Anesthesia Service and Perioperative Medicine at Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS); {dagger}Instituto de Ciências Bsicas da Saúde, Pharmacology Department, UFRGS; {ddagger}Multidisciplinary Group of Development of Biological Rhythms of Universidade de São Paulo; §Registrar of Anesthesia Service and Perioperative Medicine at Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS); ||Psychiatric Service of Hospital Materno Infantil Presidente Vargas, Hospital de Clínicas de Porto Alegre (HCPA); and ¶Hospital de Clínicas de Porto Alegre (HCPA), Psychiatric Department of School of Medicine, UFRGS, Brazil.

Address correspondence and reprint requests to Dr. Maria Paz Loayza Hidalgo, Castro Alves 167 sala 204, CEP 90430-131 – Porto Alegre, RS, Brazil. Address e-mail to mpaz@cpovo.net.


BACKGROUND: Melatonin has sedative, analgesic, antiinflammatory, antioxidative, and chronobiotic effects. We determined the impact of oral melatonin premedication on anxiolysis, analgesia, and the potency of the rest/activity circadian rhythm.

METHODS: This randomized, double-blind, placebo-controlled study included 33 patients, ASA physical status I–II, undergoing abdominal hysterectomy.

Patients were randomly assigned to receive either oral melatonin 5 mg (n = 17) or placebo (n = 16) the night before and 1 h before surgery.

The analysis instruments were the Visual Analog Scale, the State-Trait Anxiety Inventory, and the actigraphy.

RESULTS:
The number of patients that needed to be treated to prevent one additional patient reporting high postoperative anxiety and moderate to intense pain in the first 24 postoperative hours was 2.53 (95% CI, 1.41–12.22) and 2.20 (95% CI, 1.26–8.58), respectively.

The number-needed-to-treat was 3 (95% CI, 1.35–5.0) to prevent high postoperative anxiety in patients with moderate to intense pain, when compared with 7.5 (95% CI, 1.36–{infty}) in the absence of pain or mild pain.

Also, the treated patients required less morphine by patient-controlled analgesia, as assessed by repeated measures ANOVA (F[1,31] = 6.05, P = 0.02).

The rest/activity cycle, assessed by actigraphy, showed that the rhythmicity percentual of 24 h was higher in the intervention group in the first week after discharge ([21.16 ± 8.90] versus placebo [14.00 ± 7.10]; [t = –2.41, P = 0.02]).

CONCLUSIONS: This finding suggested that

*** preoperative melatonin produced clinically relevant
*** anxiolytic and analgesic effects,
*** especially in the first 24 postoperative hours.

Also, it improved the recovery of the potency of the rest/activity circadian rhythm.